Drugs / Stravix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05366842 | Apr 2022 → Apr 2025 | prostate cancer | Johns Hopkins University | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stravix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05366842 ↗ |